Glucose intake induces an increase in activator protein 1 and early growth response 1 binding activities, in the expression of tissue factor and matrix metalloproteinase in mononuclear cells, and in plasma tissue factor and matrix metalloproteinase concentrations.
暂无分享,去创建一个
[1] A. Aljada,et al. Increase in intranuclear nuclear factor κB and decrease in inhibitor κB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect , 2004 .
[2] Michael F. Wilson,et al. Anti-Inflammatory and Profibrinolytic Effect of Insulin in Acute ST-Segment–Elevation Myocardial Infarction , 2004, Circulation.
[3] A. Aljada,et al. Insulin suppresses plasma concentration of vascular endothelial growth factor and matrix metalloproteinase-9. , 2003, Diabetes care.
[4] F. Cambien,et al. Plasma Concentrations and Genetic Variation of Matrix Metalloproteinase 9 and Prognosis of Patients With Cardiovascular Disease , 2003, Circulation.
[5] A. Aljada,et al. Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. , 2002, The American journal of clinical nutrition.
[6] A. Aljada,et al. Insulin inhibits the pro-inflammatory transcription factor early growth response gene-1 (Egr)-1 expression in mononuclear cells (MNC) and reduces plasma tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1) concentrations. , 2002, The Journal of clinical endocrinology and metabolism.
[7] A. Aljada,et al. Insulin Inhibits Intranuclear Nuclear Factor κB and Stimulates IκB in Mononuclear Cells in Obese Subjects: Evidence for an Anti-inflammatory Effect? , 2001 .
[8] Valentin Fuster,et al. Thrombus Formation on Atherosclerotic Plaques: Pathogenesis and Clinical Consequences , 2001, Annals of Internal Medicine.
[9] Y. Nemerson,et al. Circulating tissue factor and thrombosis , 2000, Current opinion in hematology.
[10] A. Aljada,et al. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. , 2000, The Journal of clinical endocrinology and metabolism.
[11] S. Seregard,et al. Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization. , 2000, Experimental eye research.
[12] D. Pinsky,et al. Egr-1: is it always immediate and early? , 2000, The Journal of clinical investigation.
[13] M. Cybulsky,et al. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. , 2000, The Journal of clinical investigation.
[14] P. Freskgård,et al. Tissue factor-dependent factor VIIa signaling. , 2000, Trends in cardiovascular medicine.
[15] H Wedel,et al. Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .
[16] L. Piegas,et al. Metabolic Modulation of Acute Myocardial Infarction The ECLA Glucose-Insulin-Potassium Pilot Trial , 1998 .
[17] W. Frishman,et al. Matrix Metalloproteinases and Coronary Artery Disease: A Novel Therapeutic Target , 1997, Journal of clinical pharmacology.
[18] Amyj . Williams,et al. Inducible PDGF A-chain transcription in smooth muscle cells is mediated by Egr-1 displacement of Sp1 and Sp3. , 1997, The American journal of physiology.
[19] G. Giannelli,et al. Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. , 1997, Science.
[20] D. Steinberg,et al. Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. , 1997, Circulation.
[21] A. Charlesworth,et al. William Heberden revisited: postprandial angina-interval between food and exercise and meal composition are important determinants of time to onset of ischemia and maximal exercise tolerance. , 1997, Journal of the American College of Cardiology.
[22] E. Levin,et al. Egr-1 Activates Basic Fibroblast Growth Factor Transcription , 1996, The Journal of Biological Chemistry.
[23] J. Monroe,et al. Role of EGR1 in regulation of stimulus-dependent CD44 transcription in B lymphocytes , 1996, Molecular and cellular biology.
[24] J. Monroe,et al. Transcriptional regulation of the Icam-1 gene in antigen receptor- and phorbol ester-stimulated B lymphocytes: role for transcription factor EGR1 , 1996, The Journal of experimental medicine.
[25] Amyj . Williams,et al. Egr-1-Induced Endothelial Gene Expression: A Common Theme in Vascular Injury , 1996, Science.
[26] Amyj . Williams,et al. Interplay of Sp1 and Egr-1 in the Proximal Platelet-derived Growth Factor A-Chain Promoter in Cultured Vascular Endothelial Cells (*) , 1995, The Journal of Biological Chemistry.
[27] N. Mackman. Regulation of the tissue factor gene , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] G. Hensel,et al. Characterization of an Krox-24/Egr-1-responsive element in the human tumor necrosis factor promoter. , 1994, Biochimica et biophysica acta.
[29] V. Fuster,et al. Atherogenesis and inflammation. , 1993, European heart journal.
[30] W. Greene,et al. Cross‐coupling of the NF‐kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. , 1993, The EMBO journal.
[31] T. Nakamura,et al. Expression of the early growth response 1 and 2 zinc finger genes during induction of monocytic differentiation. , 1991, The Journal of clinical investigation.
[32] N. Andrews,et al. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. , 1991, Nucleic acids research.
[33] R. Ross,et al. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. , 1990, Arteriosclerosis.
[34] M. Sporn,et al. Promoter sequences of the human transforming growth factor-beta 1 gene responsive to transforming growth factor-beta 1 autoinduction. , 1989, The Journal of biological chemistry.
[35] N. Mackman,et al. Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. , 1989, Biochemistry.
[36] P. Verde,et al. An upstream enhancer and a negative element in the 5' flanking region of the human urokinase plasminogen activator gene. , 1988, Nucleic acids research.
[37] G. V. Berghe,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[38] A. Aljada,et al. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? , 2001, The Journal of clinical endocrinology and metabolism.
[39] R. Diaz,et al. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group. , 1998, Circulation.
[40] D. Steinberg. Oxidative Modification of LDL and Atherogenesis , 1998 .
[41] P. Dicorleto,et al. Mechanisms of monocyte recruitment and accumulation. , 1993, British heart journal.